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CASE REPORT Open Access
Case report: meningitis as a presenting
feature of anti-NMDA receptor encephalitis
Maria Stavrou1,2,3*, Jing Ming Yeo4, Alexander David Slater5, Oliver Koch6, Sarosh Irani7 and Peter Foley1,2,3
Abstract
Background: Meningitis is a very rare atypical presenting feature of anti-NMDA receptor encephalitis. In our case
report, we describe an unusual clinical presentation of anti-NMDA receptor encephalitis with a biphasic pattern of
meningitis followed by encephalitis and discuss potential mechanisms underlying this presentation. We aim to
widen the differential diagnosis to be considered in a patient presenting with clinical meningitis and pyrexia.
Case presentation: This is a case of a 33-year old Caucasian woman who initially presented with a lymphocytic
meningitis attributed to a viral infection. She subsequently developed fluctuating consciousness, agitation, visual
hallucinations, dyskinetic movements, a generalized tonic-clonic seizure, and autonomic instability. Investigations
revealed a diagnosis of anti-NMDA receptor encephalitis secondary to a previously unidentified ovarian teratoma.
She made an excellent recovery with immunotherapy and removal of the teratoma.
Conclusion: Clinicians should consider autoimmune encephalitides in individuals with meningitis, particularly
where extensive investigations fail to identify a causative pathogen and there is rapid development of an
encephalitic phenotype.
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Background
Anti-NMDA receptor encephalitis is a well-recognised
immunotherapy-responsive condition which often occurs
as a paraneoplastic phenomenon. A typical presentation is
in a young individual with a viral-like prodrome followed
by the development of severe psychiatric symptoms, mem-
ory loss, seizures, reduced consciousness and sometimes
orofacial dyskinesias, and progression to autonomic and
respiratory instability. Meningitis is a very rare presenting
feature of anti-NMDA receptor encephalitis with our lit-
erature search only revealing one other reported case. We
present a case of a 33-year old Caucasian woman who ini-
tially presented with a lymphocytic meningitis attributed
to a viral infection, but who subsequently developed clin-
ical and investigative features consistent with anti-NMDA
receptor encephalitis. The aim of this report is to present
and discuss possible mechanisms underlying this atypical
presentation.
Case presentation
A 33-year old, previously fit and well, Caucasian woman
presented to a UK acute medical unit with 2 days of grad-
ual onset pressure-like headache, fever, neck stiffness and
vomiting. There was no travel history of note or recent ill
contacts. On examination, she was febrile at 38.6 °C and
had photophobia with nuchal rigidity, however with a nor-
mal conscious level, and unremarkable systemic and
neurological examinations. Initial tests included a normal
serum white cell count and a C-reactive protein of < 1
mg/L, normal creatinine and electrolyte levels, and a nor-
mal chest radiograph. A Computed Tomography (CT) of
her brain was reported as normal with no masses, haem-
orrhage or hydrocephalus. Cerebrospinal fluid (CSF) ana-
lysis revealed an elevated white cell count of 172 × 106/L,
with complete lymphocytosis and elevated CSF pressure
of 32 cm H20 (Table 1). A working diagnosis of viral men-
ingitis was made. Following a lumbar puncture, she was
treated empirically with intravenous acyclovir 10mg/kg
three times a day pending her CSF virology polymerase
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chain reaction (PCR) screen result which came back nega-
tive after 3 days at which point the acyclovir was stopped
(Table 1). She also received paracetamol as an analgesic
and antipyretic but did not receive steroids. Her headache
improved, she was afebrile for 48 h and she was dis-
charged home after 5 days.
A week later, the clinical phenotype had evolved con-
siderably from that of pure meningitis, to meningo-
encephalitis. On representing to the Emergency
Department, she had additional clinical features of con-
fusion with impaired concentration, memory deficits and
mild dysarthria. She remained febrile. She rapidly be-
came increasingly agitated, and developed visual halluci-
nations and a generalised tonic-clonic seizure. Over 5
days, she developed a reduced conscious level alternating
with agitation and mutism. She was intubated and venti-
lated, and treated empirically with intravenous ceftriax-
one 2 g a day and acyclovir 10 mg/kg three times a day
for presumed meningoencephalitis. She was subse-
quently transferred to our hospital for further investiga-
tions and care. During this period, despite ongoing
antimicrobial therapy for a week, she had ongoing pyr-
exia and a persistently reduced Glasgow Coma Scale
(GCS) requiring critical care support. She later devel-
oped marked autonomic instability, along with new oro-
facial and upper limb dyskinetic movements.
She underwent detailed investigations for infective and
autoimmune causes of encephalitis and meningitis. Her
Magnetic Resonance Imaging (MRI) brain with contrast
showed a few tiny non-specific supratentorial white matter
T2-weighted high signal foci which were not thought to
be of clinical relevance. Otherwise the appearance of the
brain parenchyma was normal with no abnormal enhance-
ment post-contrast. A summary of her serum and CSF in-
vestigations is shown in Table 1. CSF repeatedly
demonstrated marked lymphocytosis with elevated protein
levels, along with an elevated opening pressure on one oc-
casion and a reduced CSF/serum glucose ratio on two oc-
casions. Investigations for a number of infections were
negative. An electroencephalogram showed generalized
brain wave slowing indicative of diffuse cerebral dysfunc-
tion. Serum live cell-based assay for NMDA-receptor
(NMDAR) antibodies from day 14 of illness was positive.
CT of the pelvis demonstrated a left ovarian lesion. Subse-
quent excision confirmed a stage 1A G1 immature ovarian
teratoma on histopathological examination. A diagnosis of
Table 1 Summary of serum and cerebrospinal fluid investigations
SERUM CEREBROSPINAL FLUID
(Three lumbar punctures performed on admission days 1, 13 & 23)
(reference range)
Infective Autoimmune Tumour markers
(reference range)
Admission day 1 13 23
Negative for:
HIV antigen/antibody
Hepatitis C antibody
Anti-treponemal IgG
CMV IgM and IgG
EBV IgM
Leptospirosis IgM
Borrelia antibody
Cryptococcal antigen
Blood cultures
Negative for:
Anti-VGKC
MPO & PR3-ANCA
C3 and C4
ANA
Anti-CCP
Anti-Ro
Anti-La
Anti-Smith
Anti-RNP
Anti-Scl-70
Anti-Jo
LDH: 265 (125–220 units/liter)
CA-125: 8 (0–35 units/mL)
β-HCG: < 1 (< 5 m-international
units/mL)
AFP: < 2 (< 6 ng/mL)
No paraproteins
Normal immunoglobulin
levels.
Opening pressure
(cm H20) (5–20)
32 17 Not available
White cell count
(× 106/L) (< 5)
172 (100%
lymphocytes)
85 (Differential
not available)
143 (100%
lymphocytes)
Red cell count
(×106/L) (0)
35 6 0
Protein (g/L)
(0.15–0.60)
0.77 1.07 0.32
Glucose(serum
glucose) (g/L)
(60–80% of serum)
2.3 (no serum) 2.5 (10·5) 3.8 (6·1)
Cryptococcal antigen – Negative –
ANCA – Negative –
Microscopy No organisms seen (all three samples)
Microbiology
(by PCR)
Negative for:
Bacteria: H. influenza, S. pneumoniae, N.
meningitidis (all samples)
Virus: enterovirus, HSV 1 & 2, VZV, parechovirus (all
samples)
Culture and
sensitivity
No growth, No mycobacteria (all samples)
Cytology No malignant cells detected (all samples)
HIV Human Immunodeficiency Virus, CMV Cytomegalovirus, EBV Epstein - Barr virus, PCR Polymerase Chain Reaction, Anti-VGKC Anti-voltage gated potassium
channel, MPO & PR3 ANCA Myeloperoxidase and proteinase-3 anti-neutrophil cytoplasmic antibody, C3 and C4 Complement component 3 and 4, ANA Anti-nuclear
antibody, Anti-CCP Anti-cyclic citrullinated peptide, Anti-RNP Anti-ribonucleoprotein, Anti-Scl 70 Anti-scleroderma, also known as anti-topoisomerase 1, Anti-Jo-1
Antibodies to histidyl tRNA synthetase, LDH Lactate dehydrogenase, CA-125 Cancer antigen-125, β-HCG Beta human chorionic gonadotropin, AFP Alpha-
fetoprotein, ANCA Anti-neutrophil cytoplasmic antigen, H. influenzae Haemophilus influenzae, S. pneumonia Streptococcus pneumoniae, N. meningitidis Neisseria
meningitidis, HSV Human simplex virus, VZV Varicella zoster virus
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anti-NMDAR encephalitis related to ovarian teratoma was
made. Due to a sampling error, a CSF NMDAR antibody
result was not available.
She was treated with high-dose intravenous methyl-
prednisolone 1 g a day for 5 days on day 28 of illness
followed by five cycles of plasma exchange, and subse-
quently started on prednisolone at a dose of 60 mg once
daily via a nasogastric tube. She was extubated after 3
weeks and she continued to demonstrate improvement
in her concentration, memory and language ability. After
leaving intensive care, neuropsychiatric assessment doc-
umented executive dysfunction with concrete thinking
and anxiety, however these rapidly improved. She under-
went a left salpingo-oophorectomy 2months following
her initial presentation. She was discharged from hos-
pital after 3 months at which point she was independent
in her mobility and self-care. Steroids were slowly re-
duced and stopped over 3 months as an outpatient. Fur-
ther immunotherapy was not required. Because of the
clear clinical diagnosis, supported by immunological
assay and clinical improvement, repeat CSF tests were
not clinically indicated.
Overall, she made an excellent recovery. She has
remained well and returned to work as a receptionist.
Further assessments revealed only subclinical executive
dysfunction with no major impact on her activities of
daily living. Serial gynaecological oncology reviews con-
firmed complete excision of teratoma and absence of
contralateral disease. Oncological prognosis is consid-
ered to be good. We consider the likelihood of recur-
rence of encephalitis to be low.
Discussion and conclusion
We made a definite diagnosis of anti-NMDAR encephalitis
associated with ovarian teratoma, despite an initially atyp-
ical presentation with a clinical syndrome of meningitis.
Differential diagnoses include a range of infective and
autoimmune causes of meningoencephalitis. Following
an initial illness phase of meningitis with raised CSF
pressure, and prior to availability of antibody results, her
clinical phenotype evolved to meet suggested criteria for
“probable” anti-NMDAR encephalitis [1]. The subse-
quent development of memory deficits, psychiatric dis-
turbances and seizures in the second phase of her illness
is consistent with established clinical features of this
condition [2, 3]. Rapid clinical progression to reduced
consciousness alternating with agitation, development of
autonomic instability and movement disorder is also
well-described. Definite anti-NMDAR encephalitis was
subsequently confirmed by a positive serum NMDAR
antibody live cell-based assay.
Low-grade fever and non-specific headaches have fre-
quently been reported in the prodromal phase of anti-
NMDAR encephalitis. By contrast, signs of raised
intracranial pressure including raised CSF opening pres-
sures and bilateral abducens palsies have infrequently
been reported. Also, very rarely patients with nuchal ri-
gidity have been described [4]. Our case illustrates a rare
set of presenting feature of NMDAR encephalitis with a
prodrome of florid meningitis manifesting with nuchal
rigidity, fever and elevated CSF opening pressure, lym-
phocytosis and raised protein.
The mechanisms underlying our patient’s presentation
are incompletely understood. One question is whether
this could represent post-infectious antibody generation,
as is well-recognised several weeks after HSV encephal-
itis [5]. However, the very short time interval to emer-
gence of fulminant encephalitis is against the possibility
of de novo autoantibody generation [6]. Alternatively, a
meningitis might induce transient blood-brain barrier
disruption allowing the infiltration of NMDAR-specific
B cells [2, 3]. If so, the patient should have pre-formed
circulating NMDAR-specific B cells, and perhaps this is
reflected by the finding of Dahm and colleagues who re-
ported an unexpectedly high seroprevalence of N-
methyl-D-aspartate-receptor subunit-NR1 autoanti-
bodies in patients and healthy individuals [7]. Another
possible mechanism could be that the meningitis directly
activated CNS-surveying NMDAR-reactive B cells. This
process would necessitate loss of immunological toler-
ance to this molecule and could account for the relative
rarity of meningitis as a presenting complaint of anti-
NMDAR encephalitis.
We carried out a literature search in MEDLINE and EMBASE databases for
original reports of anti-NMDA receptor encephalitis presenting with
meningitis (defined as the presence of nuchal rigidity and photophobia
in association with a headache) in humans, using the search criteria
‘anti-NMDA encephalitis’. A search between January 1990 and Septem-
ber 2017 yielded 384 potential articles. Screening of titles and abstracts
led to exclusion of 307 articles. We reviewed the full text of the
remaining 77. None described meningitis as a presenting feature. A
cited reference search (Google Scholar) however identified one report
describing meningitis as a presenting feature [4].
This case highlights meningitis as an atypical
presenting feature of anti-NMDA-receptor encephalitis.
Clinicians should consider autoimmune encephalitides
in individuals with meningitis, particularly where exten-
sive investigations fail to identify a causative pathogen
and there is rapid development of an encephalitic
phenotype. A multidisciplinary approach is required to
address the neurological, gynaecological, oncological,
and neuropsychiatric aspects of this challenging and in-
completely understood disorder.
Abbreviations
Anti-NMDAR: Anti-N-methyl-D-aspartate receptor; CSF: Cerebrospinal fluid;
CT: Computed Tomography; GCS: Glasgow Coma Scale; MRI: Magnetic
Resonance Imaging; PCR: Polymerase chain reaction
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